Medix Biochemica, a leading provider of in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to its Board of Directors. Shoff, formerly the President of the Clinical Diagnostics Division at Thermo Fisher Scientific, brings over 30 years of international healthcare experience to the role.
In a notable move towards environmental responsibility within the life sciences sector, Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program. This strategic decision marks a significant step for the global biomarker and bioanalytical solutions provider in its quest to enhance the sustainability of its laboratory operations.
In a groundbreaking move towards accelerating pandemic response capabilities, Touchlight and LenioBio have announced a strategic partnership that could potentially transform the landscape of protein therapeutics development. This collaboration brings together two cutting-edge technologies in a bid to dramatically reduce the time required for vaccine production.
In a significant move for gene therapy research, Annogen has announced a collaboration with Orchard Therapeutics to identify immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programmes. This partnership aims to advance the development of more targeted and potentially safer gene therapies for central nervous system (CNS) disorders.
London-based startup Briefly Bio has launched with £1.2 million in pre-seed funding to tackle one of the most pressing issues in scientific research: reproducibility. With an estimated 50% of preclinical research experiments failing to be reproduced, costing the industry over £50 billion annually, Briefly Bio aims to revolutionise how scientists document and share their work.
Leading diagnostics company Beckman Coulter has announced a substantial €10 million investment in its East Clare facility, reinforcing its commitment to innovation and growth in Ireland’s Mid-West region. The investment will significantly enhance the site’s diagnostics production capabilities, with the addition of two new fully automated reagent filling lines and infrastructure upgrades.
Technological partnerships The expansion features Cytiva’s Xcellerex XDR Bioreactor single-use system. Silke Fetzer-Rümpler, Senior Vice President, Commercial at Cytiva, noted the system’s scalability and potential to accelerate clinical and commercial milestones.
Researchers from Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and partners have developed a groundbreaking approach to identify pathogens in sepsis patients, potentially reducing mortality rates and improving treatment outcomes. The team has been awarded the 2024 Stifterverband Science Prize for their innovative work.
Researchers at Moffitt Cancer Center have developed a novel method for the scalable synthesis of withanolides, a class of naturally occurring compounds with significant potential in cancer treatment. This groundbreaking approach, published in Science Advances [1], could revolutionise cancer research by providing a reliable and efficient means of producing these vital compounds in large quantities.
A team of engineers at the California Institute of Technology (Caltech) has developed a groundbreaking microscopy method that promises to revolutionise biomedical imaging, digital pathology, and drug screening. The new technique, called Angular Ptychographic Imaging with Closed-form method (APIC), builds upon and surpasses the capabilities of its predecessor, Fourier ptychographic microscopy (FPM).
May 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.